Results 171 to 180 of about 8,508 (214)

Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina

open access: yesIntravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina
openaire  

Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids

open access: yesJournal of Personalized Medicine, 2022
This nationwide population-based cohort study aimed to describe the use of intravitreal injections (IVTs) of anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids in pregnant women in France and to report on the incidence of obstetric and neonatal complications.
InĂ©s Ben Ghezala   +2 more
exaly   +5 more sources

Intravitreal Corticosteroid Therapy

JAMA Ophthalmology, 2012
Dennis P Han, Dale K Heuer
exaly   +3 more sources

The intravitreal use of corticosteroids

Expert Review of Ophthalmology, 2010
The use of intravitreal steroids was first explored some 35 years ago, and the enthusiasm for its use has waxed and waned over that time. This article reviews the pharmacology of different corticosteroid agents and drug delivery systems. The literature on the utility of steroids is reviewed and categorized by retinal vascular disease entity, that is ...
Alejandro Oliver, Peter J Kertes
openaire   +1 more source

Perspectives on Verteporfin Therapy Combined With Intravitreal Corticosteroids

Archives of Ophthalmology, 2006
S INCE ITS APPROVAL IN 1999, photodynamic therapy (PDT) using verteporfin has become the most important strategy in the treatment of neovascular age-related macular degeneration (AMD). Verteporfin therapy has a proven benefit seen in many subtypes of choroidal neovascularization (CNV).
Ursula, Schmidt-Erfurth   +2 more
openaire   +2 more sources

The use of intravitreal corticosteroids, evidence-based and otherwise

Current Opinion in Ophthalmology, 2006
To provide a current update on the use of intravitreal corticosteroids as a treatment for a variety of retinal diseases.Pharmacokinetic studies demonstrate that a single 4 mg injection of intravitreal triamcinolone acetonide is present in the vitreous for up to 3 months.
Stephen M, Conti, Peter J, Kertes
openaire   +2 more sources

INTRAVITREAL CORTICOSTEROIDS IN THE TREATMENT OF EXOGENOUS FUNGAL ENDOPHTHALMITIS

Retina, 1992
A rabbit model of exogenous Candida albicans endophthalmitis was used to determine if intravitreal corticosteroids combined with an efficacious antifungal agent enhanced fungal proliferation and ocular destruction, or if the combination can suppress the inflammatory and immunogenic response that causes retinal and uveal destruction.
M L, Coats, G A, Peyman
openaire   +2 more sources

Home - About - Disclaimer - Privacy